[HTML] plos.org

[HTML][HTML] Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response

M Ustinova, L Ansone, I Silamikelis, V Rovite, I Elbere… - PLoS …, 2020 - journals.plos.org
Metformin, a biguanide agent, is the first-line treatment for type 2 diabetes mellitus due to its
glucose-lowering effect. Despite its wide application in the treatment of multiple health …
被引用次数：22 相关文章
[PDF] academia.edu

[PDF][PDF] Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response

M Ustinova, L Ansone, I Silamikelis, V Rovite, I Elbere… - PLoS ONE, 2020 - academia.edu
Metformin, a biguanide agent, is the first-line treatment for type 2 diabetes mellitus due to its
glucose-lowering effect. Despite its wide application in the treatment of multiple health …
[PDF] semanticscholar.org

[PDF][PDF] Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response

M Ustinova, L Ansone, I Silamikelis, V Rovite… - PLoS …, 2020 - pdfs.semanticscholar.org
Metformin, a biguanide agent, is the first-line treatment for type 2 diabetes mellitus due to its
glucose-lowering effect. Despite its wide application in the treatment of multiple health …

Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response

M Ustinova, L Ansone, I Silamikelis, V Rovite… - PloS …, 2020 - pubmed.ncbi.nlm.nih.gov
Metformin, a biguanide agent, is the first-line treatment for type 2 diabetes mellitus due to its
glucose-lowering effect. Despite its wide application in the treatment of multiple health …

Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response

M Ustinova, L Ansone, I Silamikelis, V Rovite, I Elbere… - PLoS ONE, 2020 - go.gale.com
Diabetes mellitus is a chronic disease affecting approximately 463 million people worldwide,
which is nearly 9.3% of the global population [1]. Type 2 diabetes mellitus (T2DM) is the …
[HTML] nih.gov

[HTML][HTML] Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response

M Ustinova, L Ansone, I Silamikelis, V Rovite, I Elbere… - PLoS ONE, 2020 - ncbi.nlm.nih.gov
Metformin, a biguanide agent, is the first-line treatment for type 2 diabetes mellitus due to its
glucose-lowering effect. Despite its wide application in the treatment of multiple health …

Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response.

M Ustinova, L Ansone, I Silamikelis, V Rovite, I Elbere… - Plos one, 2020 - europepmc.org
Metformin, a biguanide agent, is the first-line treatment for type 2 diabetes mellitus due to its
glucose-lowering effect. Despite its wide application in the treatment of multiple health …
[PDF] archive.org

[PDF][PDF] Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response

M Ustinova, L Ansone, I Silamikelis, V Rovite… - PLoS ONE, 2020 - scholar.archive.org
Metformin, a biguanide agent, is the first-line treatment for type 2 diabetes mellitus due to its
glucose-lowering effect. Despite its wide application in the treatment of multiple health …

Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response.

M Ustinova, L Ansone, I Silamikelis, V Rovite… - PLoS …, 2020 - search.ebscohost.com
Metformin, a biguanide agent, is the first-line treatment for type 2 diabetes mellitus due to its
glucose-lowering effect. Despite its wide application in the treatment of multiple health …

[引用][C] Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response

M Ustinova, L Ansone, I Silamikelis, V Rovite… - PLoS …, 2020 - ui.adsabs.harvard.edu
Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response
- NASA/ADS Now on home page ads icon ads Enable full ADS view NASA/ADS Whole-blood …